Biogenesis Ltd Company Profile

16:10 EST 16th December 2018 | BioPortfolio

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers around the globe. For more than 20 years, these customers have chosen Biogenesis for its quality, reliability, and innovation. Our ongoing commitment to quality products and services is demonstrated by our ISO 9001:2000 Quality Registration.Biogenesis, now a division of MorphoSys, is pleased to be able to bring new monoclonal antibodies developed using MorphoSys’ HuCAL® Gold library to the diagnostic and research markets. And if you don’t find the antibody you are looking for at Biogenesis, you can now order custom monoclonal antibodies from the
HuCAL® Gold library in via the Antibodies by Design division of MorphoSys. Whatever your antibody needs, Biogenesis is ready to provide the quality products and services that you can rely on.


Technology Road
BH17 7DA
United Kingdom


Phone: (+44) 1202 660006
Fax: 44 (0) 1865 852 739

News Articles [23 Associated News Articles listed on BioPortfolio]

Platelet Biogenesis Technique Allows Clinical Scale Production: Researchers

Turbulent flow activates platelet biogenesis and enables ex vivo production of clinically meaningful volumes of platelets, researchers from Japan report. Reuters Health Information

Platelet BioGenesis Receives $3.5 Million Grant from Department of Defense

Platelet Biogenesis (PBG) was awarded a two-year, $3.5 million grant from the U.S. Department of Defense (DoD). The funds are to support the company’s proprietary bioreactor to produce therapeutic a...

CLN8 safeguards lysosome biogenesis

Decapping enzymes STOP "cancer" ribosomes in their tracks

The production of ribosomes plays a central role in regulating cell cycle progression and cancer proliferation. A new study by Gaviraghi et al (2018) shows that mRNA decapping coactivator PNRC1 a...

Regulation of microRNA biogenesis and its crosstalk with other cellular pathways

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis

CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis

Drugs and Medications [0 Results]


PubMed Articles [157 Associated PubMed Articles listed on BioPortfolio]

Nop-7-associated 2 (NSA2) is required for ribosome biogenesis and protein synthesis.

Ribosome biogenesis is a fundamental cellular process and occurs mainly in the nucleolus in eukaryotes. The process is exceptionally complex and highly regulated by numerous ribosomal and non-ribosoma...

High-Intensity Exercise and Mitochondrial Biogenesis: Current Controversies and Future Research Directions.

It is well established that different types of exercise can provide a powerful stimulus for mitochondrial biogenesis. However, there are conflicting findings in the literature, and a consensus has not...

TFAP2 transcription factors are regulators of lipid droplet biogenesis.

How trafficking pathways and organelle abundance adapt in response to metabolic and physiological changes is still mysterious, although a few transcriptional regulators of organellar biogenesis have b...

Regulation of Ribosome Biogenesis in Skeletal Muscle Hypertrophy.

The ribosome is the enzymatic macromolecular machine responsible for protein synthesis. The rates of protein synthesis are primarily dependent on translational efficiency and capacity. Ribosome biogen...

Ribosome biogenesis: an emerging druggable pathway for cancer therapeutics.

Ribosomes are nanomachines essential for protein production in all living cells. Ribosome synthesis increases in cancer cells to cope with a rise in protein synthesis and sustain unrestricted growth. ...

Clinical Trials [14 Associated Clinical Trials listed on BioPortfolio]

The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise

Objectives: The research focus of the study is the production of reactive oxygen species (ROS) in patients with type 2 diabetes (T2D) in response to glutathione (GSH) supplementation and i...

"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM

This study is designed to look at the effect of Pioglitazone treatment on the body's ability to burn food in order to produce energy.

Nicotinamide Riboside and Mitochondrial Biogenesis

Mitochondria are important parts of the cell that are responsible for producing energy. The amount of energy they produce depends on how much energy the body needs to function and this ene...

Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm companies with the BCR-ABL fusion gene encoded by the Philadelphia (Ph) chromosome. The BCR-ABL fusion protein(the formation...

Risk Factors for Early Remodelling in Severe Asthma in Children

- Background: Asthma is a frequent disease characterized by bronchial hyperresponsiveness, inflammation and remodeling. Consistent epidemiological data indicate that outcome of ...

Companies [5 Associated Companies listed on BioPortfolio]

Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers ar...

Platelet BioGenesis

Platelet BioGenesis is a venture-backed, development stage biotech company creating designer platelets (PLTs+™) as a new class of therapeutics. Platelet BioGenesis has develo...

BioGenesis InvestmentGroup, LLC

BioGenesis Investment Group, LLC was originally formed to purchase technology and technology options and to develop these technologies through early development stages.Recently, BioGenesis Investment ...


Antibodies, Antigens, and other Immunoassy ReagentsContract manufacture of monoclonals, polyclonals, peptides.

MorphoSys AG

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

More Information about "Biogenesis Ltd" on BioPortfolio

We have published hundreds of Biogenesis Ltd news stories on BioPortfolio along with dozens of Biogenesis Ltd Clinical Trials and PubMed Articles about Biogenesis Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biogenesis Ltd Companies in our database. You can also find out about relevant Biogenesis Ltd Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record